Fig. 4From: TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen lossTriBAFF-CAR-T cells inhibited the development of mice B cell lymphoma in vivo. aBioluminescence images, b integrated density of tumors, c weight of tumors, and d survival in Raji xenograft mice after administering mock T, CD19-CAR-T, and TriBAFF-CAR-T cellsBack to article page